Percutaneous epicardial left atrial appendage closure: Intermediate-term results

Journal of Cardiovascular Electrophysiology

Volumn 22, Issue 1, 2011, Pages 64-70

  Bruce, Charles J ^a   Stanton, Christopher M ^a   Asirvatham, Samuel J ^a   Danielsen, Andrew J ^a   Johnson, Susan B ^a   Packer, Douglas L ^a   Friedman, Paul A ^a  

^a MAYO CLINIC   (United States)

Author keywords

anticoagulation; atrial fibrillation; left atrial appendage; stroke; transesophageal echocardiography

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPSY; CONTROLLED STUDY; DOG; ELECTROGRAPHY; HEART ATRIUM APPENDAGE; HEART MUSCLE FIBROSIS; HEART SURGERY; NONHUMAN; PRIORITY JOURNAL; THORACOTOMY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VASCULAR ACCESS;

ANIMALS; ATRIAL APPENDAGE; BODY SURFACE POTENTIAL MAPPING; CARDIOVASCULAR SURGICAL PROCEDURES; DOGS; HEART CONDUCTION SYSTEM; LONGITUDINAL STUDIES;

EID: 78751535807     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2010.01855.x     Document Type: Article

References (23)

1. Chugh SS, Blackshear JL, Shen WK, Hammill SC, Gersh BJ,: Epidemiology and natural history of atrial fibrillation: Clinical implications. J Am Coll Cardiol 2001; 37: 371-378.
2. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB, Tsang TS,: Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006; 114: 119-125.
3. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE,: Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The anticoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA 2001; 285: 2370-2375.
4. Stroke Prevention in Atrial Fibrillation Study Group Investigators: Preliminary report of the stroke prevention in atrial fibrillation study. N Engl J Med 1990; 322: 863-868.
5. Albers GW, Diener HC, Frison L, Grind M, Nevinson M, Partridge S, Halperin JL, Horrow J, Olsson SB, Petersen P, Vahanian A,: Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: A randomized trial. JAMA 2005; 293: 690-698.
6. Blackshear JL, Odell JA,: Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1996; 61: 755-759.
7. Blackshear JL, Johnson WD, Odell JA, Baker VS, Howard M, Pearce L, Stone C, Packer DL, Schaff HV,: Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation. J Am Coll Cardiol 2003; 42: 1249-1252.
8. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P,: Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: A randomised non-inferiority trial. Lancet 2009; 374: 534-542.
9. Healey JS, Crystal E, Lamy A, Teoh K, Semelhago L, Hohnloser SH, Cybulsky I, Abouzahr L, Sawchuck C, Carroll S, Morillo C, Kleine P, Chu V, Lonn E, Connolly SJ,: Left atrial appendage occlusion study (LAAOS): Results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am Heart J 2005; 150: 288-293.
10. Bayard YL, Ostermayer SH, Sievert H,: Transcatheter occlusion of the left atrial appendage for stroke prevention. Expert Rev Cardiovasc Ther 2005; 3: 1003-1008.
11. Bayard YL, Ostermayer SH, Hein R, Skowasch M, Buscheck F, Baranowski A, Heinisch C, Sievert H,: Percutaneous devices for stroke prevention. Cardiovasc Revasc Med 2007; 8: 216-225.
12. Ostermayer SH, Reisman M, Kramer PH, Matthews RV, Gray WA, Block PC, Omran H, Bartorelli AL, Della Bella P, Di Mario C, Pappone C, Casale PN, Moses JW, Poppas A, Williams DO, Meier B, Skanes A, Teirstein PS, Lesh MD, Nakai T, Bayard Y, Billinger K, Trepels T, Krumsdorf U, Sievert H,: Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: Results from the international multi-center feasibility trials. J Am Coll Cardiol 2005; 46: 9-14.
13. Fountain RB, Holmes DR, Chandrasekaran K, Packer D, Asirvatham S, Van Tassel R, Turi Z,: The PROTECT AF (WATCHMAN left atrial appendage system for embolic PROTECTion in patients with atrial fibrillation) trial. Am Heart J 2006; 151: 956-961.
14. Stollberger C, Schneider B, Finsterer J,: Serious complications from dislocation of a Watchman left atrial appendage occluder. J Cardiovasc Electrophysiol 2007; 18: 880-881.
15. Mobius-Winkler S, Schuler GC, Sick PB,: Interventional treatments for stroke prevention in atrial fibrillation with emphasis upon the WATCHMAN device. Curr Opin Neurol 2008; 21: 64-69.
16. Friedman PA, Asirvatham SJ, Dalegrave C, Kinoshita M, Danielsen AJ, Johnson SB, Hodge DO, Munger TM, Packer DL, Bruce CJ,: Percutaneous epicardial left atrial appendage closure: Preliminary results of an electrogram guided approach. J Cardiovasc Electrophysiol 2009; 20: 908-915.
17. Sosa E, Scanavacca M, d'Avila A, Pilleggi F,: A new technique to perform epicardial mapping in the electrophysiology laboratory. J Cardiovasc Electrophysiol 1996; 7: 531-536. (Pubitemid 126426338)
18. Meier B, Palacios I, Windecker S, Rotter M, Cao QL, Keane D, Ruiz CE, Hijazi ZM,: Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardiovasc Interv 2003; 60: 417-422.
19. Maisel WH,: Left atrial appendage occlusion-closure or just the beginning N Engl J Med 2009; 360: 2601-2603.
20. FDA: FDA executive summary memorandum: Watchman LAA Closure Technology, Atritech, Inc. Prepared for the April 23, 2009 Circulatory System Devices Advisory Panel. 2009.
21. Ren JF, Marchlinski FE, Callans DJ,: Left atrial thrombus associated with ablation for atrial fibrillation: Identification with intracardiac echocardiography. J Am Coll Cardiol 2004; 43: 1861-1867.
22. Bruce CJ, Friedman PA, Asirvatham S, Munger TM, Shen WK, Peterson LA, Hammill SC, Packer D,: Frequency of left atrial thrombus occurrence in patients with atrial fibrillation during pulmonary vein isolation despite anticoagulation. Circulation 2003; 108: IV-321.
23. Bunch TJ, Asirvatham SJ, Friedman PA, Monahan KH, Munger TM, Rea RF, Sinak LJ, Packer DL,: Outcomes after cardiac perforation during radiofrequency ablation of the atrium. J Cardiovasc Electrophysiol 2005; 16: 1172-1179.